catechin has been researched along with 3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Kshirsagar, S; Morton, H; Reddy, AP; Reddy, PH; Sawant, N | 1 |
Alvir, RV; Hindle, A; Kshirsagar, S; Kumar, S; Pradeepkiran, JA; Ramasubramaniam, B; Reddy, AP; Reddy, PH; Vijayan, M | 1 |
2 other study(ies) available for catechin and 3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one
Article | Year |
---|---|
Mitophagy enhancers against phosphorylated Tau-induced mitochondrial and synaptic toxicities in Alzheimer disease.
Topics: Alzheimer Disease; Animals; Catechin; Cell Line; Coumarins; DNA-Binding Proteins; High Mobility Group Proteins; Hippocampus; Mice; Mitochondria; Mitochondrial Dynamics; Mitophagy; Neurons; NF-E2-Related Factor 2; Nuclear Respiratory Factor 1; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphorylation; Synapses; Synaptophysin; tau Proteins | 2021 |
A Combination Therapy of Urolithin A+EGCG Has Stronger Protective Effects than Single Drug Urolithin A in a Humanized Amyloid Beta Knockin Mice for Late-Onset Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Catechin; Coumarins; Humans; Mice; Mitochondrial Dynamics; RNA, Messenger | 2022 |